Part 6/6:
The high cost of insulin in the United States starkly contradicts its low manufacturing cost, driven by market monopolies and complex supply chains. The Open Insulin Project presents a promising alternative by promoting open access to production protocols, fostering community labs worldwide, and ultimately aiming to make insulin a universally accessible medicine. This effort could mark a significant step toward addressing the affordability crisis and ensuring that no one has to choose between life and financial hardship because of a lack of access to this essential drug.